De novo design of mIDH1 inhibitors by integrating deep learning and molecular modeling
BackgroundMutations in the IDH1 gene have been shown to be an important driver in the development of acute myeloid leukemia, gliomas and certain solid tumors, which is a promising target for cancer therapy.MethodsBidirectional recurrent neural network (BRNN) and scaffold hopping methods were used to...
Saved in:
Main Authors: | Dingkang Sun (Author), Lulu Xu (Author), Mengfan Tong (Author), Zhao Wei (Author), Weitong Zhang (Author), Jialong Liang (Author), Xueying Liu (Author), Yuwei Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of mIDH1 R132C/S280F Inhibitors from Natural Products by Integrated Molecular Docking, Pharmacophore Modeling and Molecular Dynamics Simulations
by: Weitong Zhang, et al.
Published: (2024) -
Recent advances of IDH1 mutant inhibitor in cancer therapy
by: Wangqi Tian, et al.
Published: (2022) -
Discovery of Novel IDH1 Inhibitor Through Comparative Structure-Based Virtual Screening
by: Yuwei Wang, et al.
Published: (2020) -
Discovery of novel IDH1-R132C inhibitors through structure-based virtual screening
by: Chujiao Hu, et al.
Published: (2022) -
Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor
by: Binghao Zhao, et al.
Published: (2022)